An insightful Position Paper published by the Physician-Patient Alliance for Health & Safety (PPAHS) coinciding with the American Thoracic Society’s annual conference [ATS 2021] recognizes the need for improved technologies and procedures to measure lung dynamics and function that can be safely sustained during pandemics.
By Michael Wong, JD (Executive Director, Physician-Patient Alliance for Health & Safety)
Patients with chronic obstructive pulmonary disease (COPD) and other respiratory illnesses are more at risk of getting COVID-19. Lung function tests, such as spirometry and plethysmography, are often used to determine how well the lungs are working. These tests measure lung volume, capacity, rates of flow, and gas exchange. Information from these tests is helpful to clinicians to diagnose and determine the appropriate treatment for patients suffering from lung disorders.
Lung function testing is used to measure how well your lungs are working.